The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America

Compared to a decade ago, nearly three times as many drugs for rare diseases are slated for development. This article addresses the market access issues associated with orphan drug status in Europe and the United States in contrast to the legislation in five Latin American (LA) countries that have m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:F1000Res
Autors principals: Arnold, Renée J.G., Bighash, Lida, Bryón Nieto, Alejandro, Tannus Branco de Araújo, Gabriela, Gay-Molina, Juan Gabriel, Augustovski, Federico
Format: Artigo
Idioma:Inglês
Publicat: F1000Research 2015
Matèries:
Opinion Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367514/
https://ncbi.nlm.nih.gov/pubmed/25844162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.4268.1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars